Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

OBJECTIVE: Opioids are recommended by the World Health Organization for moderate to severe cancer pain. Oxycodone is one of the most commonly used opioids and is metabolized in the liver by CYP3A4 and CYP2D6 enzymes. The aim of this cross-sectional study was to assess the relationship between oxycod...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Andreassen, Trine Naalsund, Eftedal, Ingrid, Klepstad, Pål, Davies, Andrew, Bjordal, Kristin, Lundström, Staffan, Kaasa, Stein, Dale, Ola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2011
Gaiak:
Pharmacogenetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3249195/
https://ncbi.nlm.nih.gov/pubmed/21735164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-011-1093-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak